GAVASSO, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.930
EU - Europa 398
AS - Asia 272
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
SA - Sud America 1
Totale 5.610
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.927
CN - Cina 214
IT - Italia 96
FI - Finlandia 90
SE - Svezia 71
DE - Germania 48
VN - Vietnam 31
GB - Regno Unito 29
UA - Ucraina 29
IN - India 23
IE - Irlanda 10
NL - Olanda 8
ES - Italia 5
TW - Taiwan 4
AU - Australia 3
EU - Europa 3
RO - Romania 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
MX - Messico 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
EE - Estonia 1
FR - Francia 1
HR - Croazia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 5.610
Salva come PNG Salva come JPEG
Città #
Fairfield 924
Woodbridge 550
Chandler 501
Ann Arbor 375
Houston 362
Seattle 356
Ashburn 344
Cambridge 320
Wilmington 272
Jacksonville 105
San Diego 94
Princeton 83
Beijing 80
Des Moines 63
Medford 54
Helsinki 47
Roxbury 39
Boardman 38
Padova 33
Dong Ket 31
Nanjing 29
Shenyang 19
Falls Church 15
Hebei 15
New York 12
London 10
Nanchang 10
Milan 9
Guangzhou 8
Norwalk 8
Pune 8
Dublin 7
Jinan 7
Los Angeles 7
Kharkiv 6
Redwood City 6
Tianjin 6
Shanghai 5
Jiaxing 4
Ogden 4
Taipei 4
Bologna 3
Chicago 3
De Zilk 3
Detroit 3
Kilburn 3
Kunming 3
Ningbo 3
Washington 3
Zhengzhou 3
Acton 2
Changsha 2
Edinburgh 2
Ferentino 2
Frankfurt am Main 2
Gurgaon 2
Hangzhou 2
Hefei 2
Indiana 2
Las Vegas 2
Piacenza 2
Rockville 2
Santa Ursula 2
Segovia 2
Adelaide 1
Adliswil 1
Atlanta 1
Bern 1
Borås 1
Brussels 1
Chongqing 1
Cona 1
Delhi 1
Dubbo 1
Esslingen am Neckar 1
Foggia 1
Groningen 1
Haikou 1
Iasi 1
Islington 1
Kiev 1
Lanzhou 1
Legnago 1
Madrid 1
Montreal 1
Munich 1
Málaga 1
Noves 1
Nürnberg 1
Pinehaven 1
Portland 1
Redmond 1
Reghin 1
Riese Pio X 1
Rome 1
Santa Croce sull'Arno 1
Selargius 1
Sydney 1
São Paulo 1
Taizhou 1
Totale 4.961
Salva come PNG Salva come JPEG
Nome #
Dynamics of circulating microparticles in obesity after weight loss 143
In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context 137
null 122
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 116
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 116
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study 115
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 111
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 111
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 108
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. 107
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 105
Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease 105
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 105
Platelet factor V levels in moderate to severe congenital factor V deficiency. 103
The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. 99
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 99
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 99
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 99
Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery 99
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 99
Effects of long-term administration of recombinant human protein C in xenografted primates. 98
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. 95
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein i antibodies. A comparison with a homemade ELISA method 95
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 94
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 94
Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation 92
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 90
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 89
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants 88
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. 88
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 88
Factor VIIa-antithrombin complexes in children with ischemic stroke. 86
“In vitro” correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate 86
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. 85
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 84
Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism 83
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism. 82
Thrombosis and thrombophilia in children: a systematic review. 80
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 80
Similar hypercoagulable state and thrombosis risk in type Iand type III protein S-deficient individuals from families with mixed type I/IIIprotein S deficiency. 79
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 79
Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. 78
Factor VIIa-antithrombin complexes plasma levels in cancer patients with and without thrombosis. 78
The haemostatic system in acromegaly: a single-centre case–control study 78
Identification of a novel frameshift mutation causing a premature stop codon in a young Nigerian man with type I antithrombin deficiency. 77
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. 76
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 76
A protein S functional assay yields unsatisfactory results in patients with activated protein C resistance. 75
Circulating microparticles in carriers of prothrombin G20210A mutation. 72
Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation. 71
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 69
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 67
Local prothrombotic state in portal venous system in cirrhosis 66
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 65
Effect on thrombin generation of the "in vitro" addition of low-dose LMWH to plasma of healthy pregnant and nonpregnant women. 63
Long term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: a study of 37 patients (2 homozygous and 35 heterozygous). 62
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 60
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 54
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 53
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 47
The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study 39
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 37
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 37
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 36
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 30
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 30
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 28
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 23
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death 23
Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis" 18
Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome. 12
Whole blood thrombin generation shows a significant hypo-coagulable state in patients with decompensated cirrhosis 8
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 7
Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study 4
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 3
Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome 1
Totale 5.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.881
article - articoli 19.442
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019408 0 0 0 0 0 0 0 0 0 0 229 179
2019/20201.209 153 52 12 112 128 85 114 146 160 118 76 53
2020/20211.029 33 92 85 123 94 56 39 91 110 103 105 98
2021/20221.122 56 108 159 36 53 106 57 98 62 44 109 234
2022/2023857 168 114 49 96 139 103 5 50 85 4 39 5
2023/2024312 16 70 45 48 22 45 19 10 13 20 4 0
Totale 5.656